Coripharma sell "Enzalutamide"
Basic Information
1.3K
95
14
4.2(60)
Category
Subcategory & Sub-subcategory
Trade Type
Sell
Product Name
Enzalutamide
Details
Substance
Manufacturer(s)
Specifications
- CAS Number: 915087-33-1
- Chemical Formula: C21H16F4N4O2S
- Dosage Form: Film-coated tablet available in 40 mg, 80 mg and 160 mg strengths, with a recommended dose of 160 mg once daily
- IUPAC Name: 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-fluoro-N-methylbenzamide
- EC Number: 805-022-1
- Molecular Weight: 464.4
- Indication: Indicated for the treatment of prostate cancer
- Storage Conditions: Store below 30°C in the original package, protected from moisture
Other Information
Additional Description:
Enzalutamide treats prostate cancer, available as film-coated tablets in 40 mg, 80 mg, and 160 mg strengths, with a recommended single daily dose of 160 mg. Coripharma is developing its generic version of enzalutamide at its R&D facility in Iceland, which runs entirely on sustainable energy, with the dossier planned for Q4 2026; its business development team is available to discuss opportunities.
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Matched Products & Services
B2B matches based on trade type, category, specifications & price range
Similar Products & Services
Products & Services related to what you're viewing
People Also Viewed
Other products & services viewed by people who looked at this product
Leave your rating & comment